Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

FDA grants priority review to Hemlibra sBLA

June 5, 2018

Transfusion reductions seen with stem cell gene therapy for beta-thalassemia

June 1, 2018

Astellas and FibroGen announce topline data from Japanese phase III study of roxadustat

June 1, 2018

Doptelet becomes available in the U.S. for the treatment of thrombocytopenia

June 1, 2018

FDA places clinical hold on IND for CTX-001 in sickle cell disease

May 31, 2018

Tavalisse becomes available in the U.S.

May 30, 2018

European designation decisions for BioCryst's BCX-7353 for HAE

May 25, 2018

Portola Pharmaceuticals receives milestone payment following Andexxa approval

May 25, 2018

FDA accepts supplemental BLA and grants priority review for pediatric use of Coagadex

May 24, 2018

Hemlibra subcutaneous injection now available in Japan

May 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...